Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of VR-AD-1005 for acute watery diarrhea in cholera
PACTR202106780884401Phase 2Suspended
- Sponsor
- Vanessa Research
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cholera comparing VR-AD-1005 with Placebo (2 arms). Primary endpoint: Reduction in stool output volume. Started Aug 2021; status: suspended.
02
Drugs
VR-AD-1005
03
Conditions
cholera
Beyond the preview
Go deeper on PACTR202106780884401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202106780884401.